| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb2db62e902df84ce7c17849ebbbaeb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b051a8b33f72167c9b14f2604721c4c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8805543ef3a4e8ec2ba2d6751579a8ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cddfb907ade4d811734c86c951e81b0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a82d3102f97b63f00636c7207f0ecec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-232 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 |
| filingDate |
2011-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0455d002489f35ecccb85b878909b8a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9381de3c48ea788e40c8a1d84430306f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7801652b12b6b3ec486bc2cde80ca65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21cf32502f4e5b5f5e8c096df4928607 |
| publicationDate |
2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012029200-A1 |
| titleOfInvention |
Orally administered composition having effect of improving serum lipids, and food/beverage composition |
| abstract |
Provided are an orally administered composition having the effect of improving serum lipids, and a food/beverage composition. The orally administered composition having the effect of improving serum lipids and the food/beverage composition according to the present invention contain less than or equal to 2.0% by weight of a DHA ethyl ester composition containing greater than or equal to 75% by weight of DHA ethyl ester. Preferably, the content of the DHA ethyl ester composition is less than or equal to 1.2% by weight. Preferably, substantially no DHA ethyl ester composition containing less than or equal to 30% by weight of DHA ethyl ester is contained. |
| priorityDate |
2010-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |